Bull & Bear
Bull and Bear
Verdict: Watchlist — the moat is real but the multiple already prices the re-rating, and FY25 earnings quality is too soft to commit ahead of the H1 2026 print. Bull is right that ASMPT owns a singular qualification position — sole-supplier chip-to-substrate TCB at TSMC CoWoS and confirmed multi-customer HBM4 12-high process-of-record — and that an SMT separation could force a sum-of-parts re-rate. Bear is right that HK$1,114M of HK$1,216M FY25 PBT came from the AAMI disposal, free cash flow turned negative on a 69% jump in over-90-day past-due receivables, and the stock is paying ~80x trough P/E and 5.2x EV/sales for a business earning 5–7% operating margins against BESI's 29%. The tension that decides it is whether SEMI can sustainably print gross margin above ~48% on rising TCB mix while collections normalise — the H1 2026 result and the SMT Strategic Options outcome are the two near-term observations that settle it. Until both arrive, the asymmetry is not yet earned.
Bull Case
Bull's price target is HK$245 on a sum-of-parts of FY27E (SEMI ~HK$11B × 8x EV/sales = HK$88B; SMT ~HK$7B × 1.5x = HK$10B; plus HK$3.3B net cash; ÷ 416.7M shares ≈ HK$245). Cross-check: 35x FY27E EPS HK$5.08 = HK$178 pre-SOTP, implying ~HK$67 of separation premium. Timeline 12–18 months, bracketing the SMT decision and FY26 full-year results. The disconfirming signal is loss of the named C2S POR at TSMC CoWoS — either TSMC capex commentary citing a second-source qualification at the next CoWoS-L node, or a BESI/Hanmi press release naming a C2S TCB win at the leading foundry's OSAT partner. Secondary disconfirmer: SEMI gross margin printing below 40% in 1H 2026 even as TCB revenue grows.
Bear Case
Bear's downside target is HK$70 (~60% below HK$176.40 spot; market cap ~HK$29B vs HK$72B today). Method: FY26 consensus EPS HK$4.01 reset ~38% to HK$2.50 as TCB shipments slip and Hanmi captures incremental HBM4 share, applied at 25–28x — a broad-line back-end equipment multiple, not BESI/Hanmi pure-play. Cross-check: 30x trough HK$2.20 EPS = HK$66; 20-year average ROE 12–14% on HK$17.1B book = HK$5.50 normalised EPS at 13x trough = HK$71; three methods triangulate to HK$60–75. Timeline 12–18 months. Primary trigger: H1 2026 gross margin prints below 38% AND past-due receivables remain above HK$300M, while the SMT review concludes "retain or partnership" rather than sale or spin. The cover signal: SEMI segment gross margin sustained at ≥48% across two consecutive halves (1H26 and 2H26) — BESI's own watermark for sustained pure-play AP mix.
The Real Debate
Verdict
Watchlist. Neither side wins outright today — bull owns the moat and the catalyst, bear owns the earnings quality and the valuation — but the bear's quality-of-earnings argument carries more weight in the near term because the stock is paying ~80x trough P/E and 5.2x EV/sales for a business whose FY25 PBT was 92% JV gain and whose dividend was funded from an asset sale. The decisive tension: whether SEMI can sustainably print gross margin above ~48% on rising TCB mix while collections normalise — Bull's whole re-rate depends on it; Bear's downside depends on its failure. Bull could still be right because TCB qualification economics are genuinely scarce, the order book is already inflecting (book-to-bill 1.05, Q1 2026 net profit +204% YoY), and a clean SMT sale would force the market to add the parts rather than average them. Flips to Lean Long if H1 2026 delivers SEMI gross margin in the high-40s with over-90-day past-due receivables coming down from HK$330M AND the SMT review concludes with a sale or spin. Flips to Avoid if H1 gross margin prints below 38%, receivables stay elevated, and the SMT review concludes "retain or partnership." Durable thesis-breaker: a named C2S TCB win for BESI or Hanmi at the leading foundry's OSAT partner — that single event removes the highest-stakes qualification underwriting the entire SEMI multiple. Near-term evidence marker: the H1 2026 gross-margin and receivables print.
Watchlist — the moat is real and the catalysts are real, but valuation already prices a successful re-rate while FY25 earnings quality and negative free cash flow leave too much downside if the H1 2026 print disappoints. Wait for the print and the SMT decision before committing.